Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2001
11/07/2001CN1321151A Chemical compounds
11/07/2001CN1321149A New crystal modification III of torasemide
11/07/2001CN1321086A Mucosal originated drug delivery system and animal applications
11/07/2001CN1320439A Refreshing eyelid liniment for improving vision
11/07/2001CN1320422A Process for preparing Chinese-medicinal pills containing borneol
11/06/2001US6313311 Imidazole derivatives having affinity for alpha2 receptors
11/06/2001US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae
11/06/2001US6313172 Administering hydroxyethylthiourea derivative for therapy of pain in mammal
11/06/2001US6313164 Dithiolin derivatives, their preparation and their therapeutic effect
11/06/2001US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001US6313116 Phosphodiesterase inhibitors
11/06/2001US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein
11/06/2001CA2250251C Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
11/01/2001WO2001081590A2 Protein phosphatases
11/01/2001WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001WO2001080989A1 Transparent liquid composition
11/01/2001WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
11/01/2001WO2001080825A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
11/01/2001WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001034548A3 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use
11/01/2001WO2001030380A3 Methods and compositions for treatment of keratoconus using protease inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001029015A3 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
11/01/2001WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001US20010036449 Therapy for dry eye
11/01/2001CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2406659A1 Transparent liquid composition
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001EP0717620B1 Substituted 2-aminotetralins
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320040A Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
10/31/2001CN1320035A Antibiotic compositions for treatment of the eye, ear and nose
10/31/2001CN1319402A 眼部营养素 Eye Nutrients
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/30/2001US6310215 Pyrazolone compounds and ophthalmic plastic lens using the same
10/30/2001US6310099 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310086 Indole derivatives and medicinal compositions containing the same
10/30/2001US6310040 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309630 Non-steroidal anti-inflammatory ophthalmic suspensions
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001079156A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078723A1 Compounds and methods
10/25/2001WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078703A2 Methods and compositions for modulating alpha adrenergic receptor activity
10/25/2001WO2001078702A2 Methods and compositions for modulating alpha adrenergic receptor activity
10/25/2001WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078530A2 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
10/25/2001WO2001034546A3 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001027099A3 Bicyclic compounds composition and method for stabilizing the same
10/25/2001US20010034362 Pyrrolidine derivatives for vision and memory disorders
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 531